Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Clinical Trial ID NCT00363272

Rank	Title	Journal	Year	PubWeight™‹?›
1	A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the Pediatric Preclinical Testing Program.	Leukemia	2016	0.76